MHRA Drug Safety Update April 2023
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections [...]
The post MHRA Drug Safety Update April 2023 appeared first on PSNC Website.
Recent Comments